Anti-tumour effects of combined lenvatinib and EGFR Inhibition in advanced differentiated thyroid cancer cells

Key Points

• Antitumour effects were observed with the combined treatment approach, enhancing cancer cell response.
• The study noted significant reductions in cell proliferation and increased apoptosis in treated cancer cells.
• Analysis of advanced differentiated thyroid cancer cells showed marked sensitivity to the dual inhibition strategy.
• These findings highlight the potential for improved therapies in managing resistant thyroid cancer cases.